
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.(AVXL)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · AVXL · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Anavex Life Sciences Corp.内部人在过去近12个月买卖活动混合。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
AVXL 季度内部人买卖趋势
AVXL 内幕交易卖出 · AVXL 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · AVXL CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
AVXL 高管卖出股份 · AVXL 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Sep 11, 2025 | MISSLING CHRISTOPHER U President and CEO · Director | Option | 187,500 | $945K | Form 4 |
| Sep 11, 2025 | MISSLING CHRISTOPHER U President and CEO · Director | Other | 145,048 | $1.39M⚡ | Form 4 |
| Mar 24, 2025 | MISSLING CHRISTOPHER U President and CEO · Director | Option | 500,000 | $460K | Form 4 |
| Mar 24, 2025 | MISSLING CHRISTOPHER U President and CEO · Director | Other | 282,497 | $2.72M⚡ | Form 4 |
| Jun 14, 2024 | Donhauser Peter D.O. Director | Purchase | 2,835 | $10K | Form 4 |
| May 15, 2024 | Thomas Steffen Director | Purchase | 5,000 | $23K | Form 4 |
| Mar 28, 2024 | MISSLING CHRISTOPHER U President and CEO · Director | Option | 73,380 | $97K | Form 4 |
| Mar 28, 2024 | MISSLING CHRISTOPHER U President and CEO · Director | Sale | 73,380 | $375K | Form 4 |
| Jun 28, 2023 | MISSLING CHRISTOPHER U President and CEO · Director | Option | 268,000 | $429K | Form 4 |
| Jun 29, 2023 | MISSLING CHRISTOPHER U President and CEO · Director | Option | 232,000 | $371K | Form 4 |
| Jun 28, 2023 | MISSLING CHRISTOPHER U President and CEO · Director | Sale | 268,000 | $2.14M⚡ | Form 4 |
| May 25, 2022 | Skarpelos Athanasios Director | Sale | 50,000 | $453K | Form 4 |
| Jun 29, 2021 | MISSLING CHRISTOPHER U President and CEO · Director | Option | 51,620 | $68K | Form 4 |
| Jun 29, 2021 | MISSLING CHRISTOPHER U President and CEO · Director | Sale | 51,620 | $1.34M⚡ | Form 4 |
| Jun 29, 2021 | Boenisch Sandra PFO and Treasurer | Option | 35,000 | $207K | Form 4 |
| Jun 29, 2021 | Boenisch Sandra PFO and Treasurer | Option | 106,696 | $350K | Form 4 |
| Jun 29, 2021 | Boenisch Sandra PFO and Treasurer | Option | 25,000 | $142K | Form 4 |
| Jun 29, 2021 | Boenisch Sandra PFO and Treasurer | Sale | 166,696 | $4.42M⚡ | Form 4 |
| May 21, 2021 | FAVUS ELLIOT Director | Option | 50,000 | $148K | Form 4 |
| May 21, 2021 | FAVUS ELLIOT Director | Option | 1,500 | $9K | Form 4 |
| May 21, 2021 | FAVUS ELLIOT Director | Option | 1,500 | $8K | Form 4 |
| May 21, 2021 | FAVUS ELLIOT Director | Option | 1,500 | $7K | Form 4 |
| May 21, 2021 | FAVUS ELLIOT Director | Option | 1,500 | $8K | Form 4 |
| May 21, 2021 | FAVUS ELLIOT Director | Option | 1,500 | $8K | Form 4 |
| May 21, 2021 | FAVUS ELLIOT Director | Option | 50,000 | $46K | Form 4 |
MISSLING CHRISTOPHER U
President and CEO · Director
日期
Sep 11
股数
187,500
均价
$5.04
总金额
$945K
MISSLING CHRISTOPHER U
President and CEO · Director
日期
Sep 11
股数
145,048
均价
$9.58
总金额
$1.39M ⚡
MISSLING CHRISTOPHER U
President and CEO · Director
日期
Mar 24
股数
500,000
均价
$0.92
总金额
$460K
MISSLING CHRISTOPHER U
President and CEO · Director
日期
Mar 24
股数
282,497
均价
$9.63
总金额
$2.72M ⚡
MISSLING CHRISTOPHER U
President and CEO · Director
日期
Mar 28
股数
73,380
均价
$1.32
总金额
$97K
MISSLING CHRISTOPHER U
President and CEO · Director
日期
Mar 28
股数
73,380
均价
$5.11
总金额
$375K
MISSLING CHRISTOPHER U
President and CEO · Director
日期
Jun 28
股数
268,000
均价
$1.60
总金额
$429K
MISSLING CHRISTOPHER U
President and CEO · Director
日期
Jun 29
股数
232,000
均价
$1.60
总金额
$371K
MISSLING CHRISTOPHER U
President and CEO · Director
日期
Jun 28
股数
268,000
均价
$7.98
总金额
$2.14M ⚡
MISSLING CHRISTOPHER U
President and CEO · Director
日期
Jun 29
股数
51,620
均价
$1.32
总金额
$68K
MISSLING CHRISTOPHER U
President and CEO · Director
日期
Jun 29
股数
51,620
均价
$26.00
总金额
$1.34M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AVXL 内幕交易
AVXL 内幕交易
Anavex Life Sciences Corp.(AVXL)内幕交易数据来源于公司内部人(包括MISSLING CHRISTOPHER U (President and CEO · Director))提交的SEC Form 4申报文件。过去12个月内,1位内部人向SEC提交了交易申报。AVXL内部人近期买卖活动混合,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Anavex Life Sciences Corp.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
AVXL 内幕交易 · 5个问题Anavex Life Sciences Corp.(AVXL)的内部人包括高管和董事,如MISSLING CHRISTOPHER U (President and CEO · Director)等。过去12个月内,1位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026